Amy Lum

6.0k total citations · 2 hit papers
55 papers, 2.7k citations indexed

About

Amy Lum is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, Amy Lum has authored 55 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Obstetrics and Gynecology, 19 papers in Reproductive Medicine and 16 papers in Molecular Biology. Recurrent topics in Amy Lum's work include Endometrial and Cervical Cancer Treatments (21 papers), Ovarian cancer diagnosis and treatment (18 papers) and Sarcoma Diagnosis and Treatment (8 papers). Amy Lum is often cited by papers focused on Endometrial and Cervical Cancer Treatments (21 papers), Ovarian cancer diagnosis and treatment (18 papers) and Sarcoma Diagnosis and Treatment (8 papers). Amy Lum collaborates with scholars based in Canada, United States and Germany. Amy Lum's co-authors include David G. Huntsman, Jessica N. McAlpine, Samuel Leung, Aline Talhouk, Winnie Yang, Melissa K. McConechy, C. Blake Gilks, Anthony N. Karnezis, Janine Senz and Michael S. Anglesio and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Amy Lum

52 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Confirmation of ProMisE: A simple, genomics‐based clinical classifier for endometrial cancer

2017 631 citations Aline Talhouk, Melissa K. McConechy et al. Cancer profile →
Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series

2018 490 citations Stefan Kommoss, Melissa K. McConechy et al. Annals of Oncology profile →

Peers

Amy Lum

PRM

Tsui-Lien Mao Taiwan

Lingying Wu China

J.G. Aalders Netherlands

Danhua Shen China

Sohei Yamamoto Japan

Karin Boman Sweden

Ruth A. Lininger United States

Trilok Parekh United States

Jean‐Michel Foidart Belgium

Robert E. Emerson United States

Tsui-Lien Mao Taiwan

Amy Lum

513 ×0.3

1.4k ×1.3

2.0k ×2.8

654 ×1.1

259 ×0.6

PRM

Citations per year, relative to Amy Lum Amy Lum (= 1×) peers Tsui-Lien Mao

Countries citing papers authored by Amy Lum

Since Specialization

Citations

This map shows the geographic impact of Amy Lum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Lum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Lum more than expected).

Fields of papers citing papers by Amy Lum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Lum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Lum. The network helps show where Amy Lum may publish in the future.

Co-authorship network of co-authors of Amy Lum

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Lum. A scholar is included among the top collaborators of Amy Lum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Lum. Amy Lum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jamieson, Amy, Jutta Huvila, Samuel Leung, et al.. (2025). Co-existent endometrial and ovarian carcinoma: molecular and pathological features define low risk entity. International Journal of Gynecological Cancer. 35(8). 101957–101957.

Jamieson, Amy, Marcel Grube, Samuel Leung, et al.. (2024). Recurrence rates and patterns of recurrence in stage IA p53abn endometrial cancer with and without myometrial invasion. International Journal of Gynecological Cancer. 34(4). 544–549. 5 indexed citations

Pors, Jennifer, Amy Lum, Samuel Leung, et al.. (2024). Papillary and ductal patterns of mesonephric‐like adenocarcinomas are often overlooked: a retrospective revaluation of over 1000 endometrial carcinomas. Histopathology. 86(6). 862–877. 2 indexed citations

Jamieson, Amy, Dawn R. Cochrane, J. Maxwell Douglas, et al.. (2024). Targeted and Shallow Whole-Genome Sequencing Identifies Therapeutic Opportunities in p53abn Endometrial Cancers. Clinical Cancer Research. 30(11). 2461–2474. 11 indexed citations

Rebchuk, Alexander D., Justin Z. Wang, Farshad Nassiri, et al.. (2024). Molecular prognostication in grade 3 meningiomas and p16/MTAP immunohistochemistry for predicting CDKN2A/B status. Neuro-Oncology Advances. 6(1). vdae002–vdae002. 2 indexed citations

Ronsley, Rebecca, Joanna Triscott, Joseph Stanek, et al.. (2023). Outcomes of a radiation sparing approach in medulloblastoma by subgroup in young children: an institutional review. Child s Nervous System. 39(8). 2095–2104. 3 indexed citations

Huvila, Jutta, Emily F. Thompson, Amy Lum, et al.. (2023). Subclonal p53 immunostaining in the diagnosis of endometrial carcinoma molecular subtype. Histopathology. 83(6). 880–890. 17 indexed citations

Orr, Natasha L., Arianne Albert, Amy Lum, et al.. (2023). KRAS mutations and endometriosis burden of disease. The Journal of Pathology Clinical Research. 9(4). 302–312. 17 indexed citations

Jamieson, Amy, Melissa K. McConechy, Amy Lum, et al.. (2023). Harmonized molecular classification; assessment of a single-test ProMisE NGS tool. Gynecologic Oncology. 175. 45–52. 14 indexed citations

10.

Wong, Derek, Victor Wong, Amy Lum, et al.. (2020). TRIM25 promotes Capicua degradation independently of ERK in the absence of ATXN1L. BMC Biology. 18(1). 154–154. 9 indexed citations

11.

Britton, Heidi, Leo Huang, Amy Lum, et al.. (2019). Molecular classification defines outcomes and opportunities in young women with endometrial carcinoma. Gynecologic Oncology. 153(3). 487–495. 89 indexed citations

12.

Kommoss, Stefan, Melissa K. McConechy, F. Kommoss, et al.. (2018). Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series. Annals of Oncology. 29(5). 1180–1188. 490 indexed citations breakdown →

13.

Talhouk, Aline, Melissa K. McConechy, Samuel Leung, et al.. (2017). Confirmation of ProMisE: A simple, genomics‐based clinical classifier for endometrial cancer. Cancer. 123(5). 802–813. 631 indexed citations breakdown →

14.

Yanagida, Satoshi, Michael S. Anglesio, Tayyebeh M. Nazeran, et al.. (2017). Clinical and genetic analysis of recurrent adult-type granulosa cell tumor of the ovary: Persistent preservation of heterozygous c.402C>G FOXL2 mutation. PLoS ONE. 12(6). e0178989–e0178989. 11 indexed citations

15.

Cochrane, Dawn R., Michael S. Anglesio, Yi Kan Wang, et al.. (2017). LINE-1 retrotransposon-mediated DNA transductions in endometriosis associated ovarian cancers. Gynecologic Oncology. 147(3). 642–647. 13 indexed citations

16.

Talhouk, Aline, Lien Hoang, Melissa K. McConechy, et al.. (2016). Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: Earlier prognostic information to guide treatment. Gynecologic Oncology. 143(1). 46–53. 154 indexed citations

17.

Färkkilä, Anniina, Melissa K. McConechy, Winnie Yang, et al.. (2016). FOXL2 402C>G Mutation Can Be Identified in the Circulating Tumor DNA of Patients with Adult-Type Granulosa Cell Tumor. Journal of Molecular Diagnostics. 19(1). 126–136. 24 indexed citations

18.

Li-Chang, Hector, Amy Lum, Esther Kong, et al.. (2015). Retrospective review using targeted deep sequencing reveals mutational differences between gastroesophageal junction and gastric carcinomas. BMC Cancer. 15(1). 32–32. 29 indexed citations

19.

Fathi, Amir T., Darrell R. Borger, Andrew M. Brunner, et al.. (2015). Detection of Dual IDH1 and IDH2 Mutations by Targeted Next-Generation Sequencing in Acute Myeloid Leukemia and Myelodysplastic Syndromes. Journal of Molecular Diagnostics. 17(6). 661–668. 30 indexed citations

20.

Lum, Amy, Jianqiang Huang, C. Richard Hutchinson, & Camilla M. Kao. (2004). Reverse engineering of industrial pharmaceutical-producing actinomycete strains using DNA microarrays. Metabolic Engineering. 6(3). 186–196. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact